Activated natural killer (NK) cells mediate graft-versus-tumor (GVT) effects but inhibit graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT).

被引：0
|
作者：
Murphy, WJ
Asai, O
Tian, Z
Hornung, R
Longo, DL
机构：
[1] NCI,LLB,DBS,FREDERICK,MD 21702
[2] NCI,BCDP,SAIC FREDERICK,FCRDC,FREDERICK,MD 21702
[3] NIA,BALTIMORE,MD 21224
来源：
FASEB JOURNAL | 1996年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：2509 / 2509
页数：1
相关论文
共 50 条
  • [21] Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation
    Schmaltz, C
    Alpdogan, O
    Muriglan, SJ
    Kappel, BJ
    Rotolo, JA
    Ricchetti, ET
    Greenberg, AS
    Willis, LM
    Murphy, GF
    Crawford, JM
    van den Brink, MRM
    BLOOD, 2003, 101 (06) : 2440 - 2445
  • [22] GRAFT-VERSUS-TUMOR EFFECT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN THE SETTING OF UNRELATED TRANSPLANTATION
    Cho, B. S.
    Yahng, S. S.
    Lee, S. E.
    Eom, K. S.
    Kim, Y. J.
    Kim, H. J.
    Lee, S.
    Min, C. K.
    Cho, S. G.
    Kim, D. W.
    Lee, W. J.
    Min, W. S.
    Park, C. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 448 - 448
  • [23] Ceacam1 Separates Graft-versus-Host-Disease from Graft-versus-Tumor Activity after Experimental Allogeneic Bone Marrow Transplantation
    Lu, Sydney X.
    Kappel, Lucy W.
    Charbonneau-Allard, Anne-Marie
    Atallah, Renee
    Holland, Amanda M.
    Turbide, Claire
    Hubbard, Vanessa M.
    Rotolo, Jimmy A.
    Smith, Marsinay
    Suh, David
    King, Christopher
    Rao, Uttam K.
    Yim, Nury
    Bautista, Johanne L.
    Jenq, Robert R.
    Penack, Olaf
    Na, Il-Kang
    Liu, Chen
    Murphy, George
    Alpdogan, Onder
    Blumberg, Richard S.
    Macian, Fernando
    Holmes, Kathryn V.
    Beauchemin, Nicole
    van den Brink, Marcel R. M.
    PLOS ONE, 2011, 6 (07):
  • [24] SIGNIFICANCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NAKAMURA, H
    TESHIMA, H
    HIRAOKA, A
    SHIBATA, H
    INOUE, T
    MASAOKA, T
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1627 - 1633
  • [25] GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YOSHIKAWA, S
    AKAO, Y
    HIRAIWA, A
    SAO, H
    YAMAUCHI, T
    TAHARA, T
    YOSHIKAWA, H
    MATSUYAMA, K
    KIMURA, S
    KITAYAMA, S
    TANABE, S
    UNO, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 509 - 518
  • [26] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION
    KORNGOLD, R
    SPRENT, J
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 197 (01): : 12 - 18
  • [27] Gastrointestinal graft versus host disease (GI-GVHD) in allogeneic bone marrow transplantation (allo-BMT)
    Jahani, M
    Ghavamzadeh, A
    Shahrasbi, A
    Khodabandeh, A
    Bybordi, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S115 - S115
  • [28] ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANTATION
    PARKER, N
    COHEN, T
    NURSING CLINICS OF NORTH AMERICA, 1983, 18 (03) : 569 - 577
  • [29] ENHANCEMENT OF GRAFT-VERSUS-LEUKEMIA (GVL) ACTIVITY BY NATURAL-KILLER (NK) CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    DEWITTE, T
    PREIJERS, F
    SCHATTENBERG, A
    WESSELS, J
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 581 - 581
  • [30] Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation
    Mullen, CA
    LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 503 - 510
12345